Asence Pharma Pvt Ltd commences new plant at Ranoli, Vadodara

Asence Pharma Pvt., Ltd. a subsidiary of Ambalal Sarabhai Enterprises Limited has commenced its new oncology and synthetic API plant at Ranoli, Vadodara.

The new API plant is set up to meet all domestic and international regulatory standards and will manufacture niche molecules that have a global requirement.

Asence Pharma Pvt. Ltd. specializes in the supply of quality pharmaceutical preparations (Bulk Drugs and Formulations) to domestic and international markets. Asence through its operations in India and USA, markets and distributes pharmaceutical preparations worldwide and has more than 100 registered products internationally with an impressive pipeline and capability for development of new medicines.

Shares of AMBALAL SARABHAI ENTERPRISES LTD. was last trading in BSE at Rs. 23.04 as compared to the previous close of Rs. 23.29. The total number of shares traded during the day was 37372 in over 175 trades.

The stock hit an intraday high of Rs. 23.50 and intraday low of 22.93. The net turnover during the day was Rs. 862034.00.

Source : Equity Bulls

Keywords

AMBALALSARABHAIENTERPRISES INE432A01017 AsencePharma NewPlant Ranoli Vadodara